Association between GSTM1, GSTT1, and GSTP1 variants and the risk of end stage renal disease

References

• Zoccali C, Kramer A, Jager KJ. Chronic kidney disease and end-stage renal disease—a review produced to contribute to the report ‘the status of health in the European Union: Towards a healthier Europe’. NDT Plus. 2010;3:210–224.
   Google Scholar
• Lacquaniti A, Boliqnano D, Donato V, Bono C, Fazio MR, Buemi M. Alterations of lipid metabolism in chronic nephropathies: Mechanisms, diagnosis and treatment. Kidney Blood Press Res. 2010;33:100–110.
   PubMed Web of Science ®Google Scholar
• Farouk H, Kandil D, Kamel S, Elghoroury EA, Elshamaa MF, Sabry S. Effect of GSTM1 and GSTT1 deletions in the development of oxidative stress in children with chronic kidney disease. J Clin Basic Cardiol. 2013;16:1–5.
   Google Scholar
• Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem. 2011;44: 1189–1198.
   PubMed Web of Science ®Google Scholar
• Lin YS, Hung SC, Wei YH, Tarng DC. GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients. J Am Soc Nephrol. 2009;20:405–415.
   PubMed Web of Science ®Google Scholar
• Suvakov S, Damjanovic T, Stefanovic A. Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among hemodialysis patients. Nephrol Dial Transplant. 2013;28:202–212.
   PubMed Web of Science ®Google Scholar
• Buzio L, De Palma G, Mazzoni P, et al. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals. Occup EnvironMed. 2003;60:789–793.
   PubMed Web of Science ®Google Scholar
• Mannervick B, Awasthi YC, Board PG et al. Nomenclature for human glutathione transferases. Biochem J. 1995;282:305–306.
   Google Scholar
• Vos RM, Van Bladeren PJ. Glutathione S-transferases in relation to their role in the biotransformation of xenobiotics. Chem Biol Interact. 1990;75:241–265.
   PubMed Web of Science ®Google Scholar
• Katoh T, Naqata N, Kuroda Y, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–1859.
   PubMed Web of Science ®Google Scholar
• Kumar M, Agarwal SK, Goel SK. Lung cancer risk in north Indian population: Role of genetic polymorphisms and smoking. Mol Cell Biochem. 2009;322:73–79.
   PubMed Web of Science ®Google Scholar
• Yalin S, Hatungil R, Tamer L, et al. Glutathione S-transferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell Biochem Funct. 2007;25:509–513.
   PubMed Web of Science ®Google Scholar
• Sweeney C, Farrow DC, Schwartz SM, Eaton DL, Checkoway H, Vaughan TL. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: A casecontrol study. Cancer Epidemiol Biomarkers Prev. 2000;9:449–454.
   PubMed Web of Science ®Google Scholar
• De flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 1997;11:1021–1031.
   PubMed Web of Science ®Google Scholar
• Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   Web of Science ®Google Scholar
• Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M, Pourmotabbed T. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem. 2008;41:932–936.
   PubMed Web of Science ®Google Scholar
• Nomani H, Mozafari H, Ghobadloo SM, Rahimi Z, Raygani AV, Rahimi MA. The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran. Mol Cell Biochem. 2011;354:181–187.
   PubMed Web of Science ®Google Scholar
• Bahrehmand F, Vaisi-Raygani A, Rahimi Z, et al. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: Influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report. Lupus. 2014;23:263–272.
   PubMed Web of Science ®Google Scholar
• Kao MP, Ang DS, Pall A, Struthers AD. Oxidative stress in renal dysfunction: Mechanisms, clinical sequelae and therapeutic options. J Hum Hypertens. 2010;24:1–8.
   PubMed Web of Science ®Google Scholar
• He N, Singhal SS, Awasthi S, Zhao T, Boor PJ. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro. Toxicol Appl Pharmacol. 1999;158:177–185.
   PubMed Web of Science ®Google Scholar
• Ketterer B. Glutathione S-transferases and prevention of cellular free radical damage. Free Radic Res. 1998;28:647–658.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Tripathi G, Khan F, Sharma R, Baburaj VP. Relationship between GSTs gene polymorphism and susceptibility to end stage renal disease among North Indians. Ren Fail. 2007;29:947–953.
   PubMed Web of Science ®Google Scholar
• Datta SK, Kumar V, Pathak R, et al. Association of glutathione Stransferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease. Ren Fail. 2010;32:1189–1195.
   PubMed Web of Science ®Google Scholar
• Datta SK, Kumar V, Ahmed RS, Tripathi AK, Kalra OP, Banerjee BD. Effect of GSTM1 and GSTT1 double deletions in the development of oxidative stress in diabetic nephropathy patients. Indian J Biochem Biophys. 2010;47:100–103.
   PubMed Web of Science ®Google Scholar
• Yang Y, Kao MT, Chang CC, et al. Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int J Mol Med. 2004;14:855–859.
   PubMed Web of Science ®Google Scholar
• Tiwari AK, Prasad P, B KT, et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes. J Diabetes Complications. 2009;23:102–111.
   PubMed Web of Science ®Google Scholar
• Asefi M, Vaisi-Raygani A, Bahrehmand F, et al. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis. Br J Dermatol. 2012;167:1279–1286.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Ahmadi R, Vaisi-Raygani A, Rahimi Z, Bahrehmand F, Parsian A. Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: Influence on lipid and lipoprotein metabolism and oxidative stress. J Matern Fetal Neonatal Med. 2013;26:1590–1594.
   PubMed Web of Science ®Google Scholar
• Osorio A, Ortega E, de Haro T, Torres JM, Sanchez P, Ruiz-Reguena E. Lipid profiles and oxidative stress parameters in male and female hemodialysis patients. Mol Cell Biochem. 2011;353:59–63.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007;116:85–97.
   PubMed Web of Science ®Google Scholar
• Walker LS, Sansom DM. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immuno. 2011;11:852–863.
   PubMed Web of Science ®Google Scholar